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Lifestyle factors, particularly dietary intake, have 
been recognized as important, modifiable risk 
factors for cardiovascular disease (CVD). 
Consuming a heart-healthy diet (lower in 
saturated fats and rich in fruits and vegetables, 
whole grains, fish and lean meats; calorie con-
trolled; and moderate sodium intake), as well as 
engaging in regular physical activity, lowers the 
individual’s risk for CVD. The majority of stud-
ies evaluated the relationship between lifestyle 
and atherosclerosis and, subsequently, coronary 
artery disease, whereas little is known about the 
influence of lifestyle on arrhythmias. 
The aim of this article is to review the evi-
dence relating to some aspects of lifestyle and 
atrial fibrillation (AF) in order to provide both 
an understanding and limitations of our know-
ledge, as well as provide recommendations for 
patients with known or suspected arrhythmia 
with regards to lifestyle.
Atrial fibrillation is the most common arrhyth-
mia in clinical practice. It is estimated to cur-
rently affect over 6 million patients in Europe 
and approximately 3 million in the USA, and 
this number is projected to at least double in the 
next 25 years owing to the aging population [1].
The mechanism by which lifestyle influences 
AF is related to the effects of nutritional and 
behavioral habits on the development of athero-
sclerotic plaque, so that the link with arrhythmias 
extends to coronary artery disease. Furthermore, 
lifestyle deeply influences the development of 
cardiac disease strictly related to AF, that is, 
hypertension, left ventricular hypertrophy and 
cardiomyopathy. Historically, coronary artery 
disease and left ventricular cardio myopathy have 
been regarded as the main causes of ventricular 
arrhythmia and sudden cardiac death (SCD). 
Similarly, in a substantial number of patients, 
AF develops in the presence of structural heart 
disease, however, in a number of patients it 
occurs in the absence of structural heart disease. 
It has been suggested that a nonhealthy lifestyle 
could also act as trigger for AF. 
Diet, obesity & atrial fibrillation
The ongoing obesity epidemic, along with the 
health benefits of weight loss, has been well 
established and national dietary weight loss 
guidelines (i.e., energy-restricted, low in fat, 
high in carbohydrate) have been challenged [2]. 
Certain dietary patterns can influence cardio-
vascular health by modifying traditional risk 
factors such as obesity, dyslipidemia and hyper-
tension, as well as new emerging risk factors; 
that is, systemic inflammation, insulin sensitiv-
ity, oxidative stress, endothelial dysfunction, 
prothrombotic status and cardiac arrhyth-
mias [3,4]. Moreover, some dietary components, 
such as caffeine, alcohol and fish-derived long-
chain polyunsaturated fatty acids (PUFAs), 
influence CVD morbidity and mortality [5–7]. 
However, the effect of dietary patterns and 
specific dietary factors on cardiac arrhythmias 
is not well established. 
Obesity is a strong risk factor of CVD. 
Over the past decade, the prevalence of over-
weight individuals and obesity in the US 
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population including children and adolescents has increased [8]. 
Approximately 65% of US adults are classified as overweight and 
more than 30% of US adults are obese [9].
Currently, the typical American (Western) diet is estimated 
to derive 49% of its calories from carbohydrates, 34% from 
fat, and 12–16% from protein [10]. Proposals to alter the pro-
portions and/or types of macronutrients in this diet have been 
made for weight loss and cardiovascular health [11]. The ideal 
strategy entails the intake of a low-calorie, low-fat diet; how-
ever, some alternative approaches including high protein and 
low carbohydrate have been proposed. Although restriction of 
caloric intake is an intuitive strategy to achieve weight loss, 
the effect of changes in dietary macronutrient composition 
has been a subject of greater controversy. Several randomized 
trials that compared low carbohydrate with low-fat diets in 
overweight/obese patients demonstrated that a low-carbohy-
drate diet appears more effective than a low-fat diet in causing 
short-term, albeit un sustained, weight loss. One mechanism 
by which low-carbohydrate diets induce immediate weight loss 
is believed to be ketosis-induced diuresis and loss of appetite. 
Alternative mechanisms have included the highly restricted 
food choices that come with the simplistic design of the diet 
and the appetite-suppressing or satiety-inducing properties of 
the diet [12].
In the case of low-carbohydrate diets, there is a concern that 
excessive dietary protein intake and excessive fat intake can 
occur and potentially increase long-term risks for CVD. On 
the contrary, when dietary fat intake is severely restricted it 
could result in biochemical evidence of essential fatty acid defi-
ciency. Some clinical consequences have been reported, includ-
ing tachyarrhythmia, especially when low-fat intake persists for 
several years [13,14].
Obesity is an important risk factor of AF. The relationship 
between obesity and AF has been demonstrated in several popu-
lation studies including the Framingham Heart study (FHS) and 
the Danish Diet, Cancer, and Health Study [15,16]. The Danish 
Study first reported an increased risk of AF by an increasing 
BMI. In that population the risk rises for about 8% per BMI 
unit increment [16]. The mechanism by which obesity contrib-
utes to an increased risk of AF is related to morphofunctional 
changes [17]. Obesity increases blood pressures, increases left 
ventricular volumes and hypertrophy, increases wall stress, and 
increases systolic and/or diastolic dysfunction [18]. In addition to 
left ventricular (LV) structural abnormalities, obesity also leads 
to left atrial (LA) enlargement, both from increased circulating 
blood volume, as well as abnormal LV diastolic filling. Weight 
reduction in obese subjects is associated with a regression of 
these abnormalities [19].
In the FHS, obese subjects showed a 45–50% increased risk for 
incident AF compared with subjects with normal BMI, indepen-
dently from other cardiovascular risk factors [15]. In this cohort 
of patients, after adjustment for LA diameter, BMI was no longer 
associated with AF risk. The investigators concluded that the 
effect of obesity was mediated by LA dilatation. This hypothesis 
is strongly supported by data from Atrial Fibrillation Follow-up 
Investigation of Rhythm Management (AFFIRM) study that 
found that obesity was associated with a higher incidence of AF 
recurrence and greater AF burden [20]. 
The primary therapeutic approach in obese patients is to 
decrease caloric intake and increase caloric expenditure by modi-
fying lifestyle [16]. Physical activity is part of a healthy lifestyle. 
The health-promoting effects of regular physical activity on CVD 
are well established. Regular exercise directly and positively affects 
cardiac physiology (e.g., increased myocardial oxygen supply and 
enhanced myocardial contractility), both in the general population 
and in patients with CVD. 
Different dietary components have been suggested as important 
modifiable risk factors for CVD. Although traditionally nutri-
tional research has focused primarily on single nutrients or foods, 
interest is growing in dietary patterns that consider the complexity 
of the overall diet. 
Some dietary patterns have shown positive effects on CVD. 
The Asian ‘vegetable-rich’ pattern, characterized by a frequent 
consumption of vegetables, fruit, soy products, seaweeds and fish 
is inversely related to cardiovascular mortality, whereas patterns 
characterized by a frequent consumption of meat and butter are 
directly related to CVD [21,22].
A very popular healthy diet is the Dietary Approaches to 
Stop Hypertension (DASH) diet, which is high in fruits and 
vegetables, moderate in low-fat dairy products and low in ani-
mal protein but with substantial amounts of plant protein from 
legumes and nuts. The DASH diet induces a reduction in both 
systolic and diastolic blood pressure among hypertensive and 
normotensive individuals [23]. In fact, this diet pattern shows 
greater improvement in blood pressure than one high in fruits 
and vegetables only. Weight is also directly associated with 
blood pressure. With rare exception, trials have documented 
that weight loss lowers blood pressure. No data are available on 
the effects of the DASH diet on cardiac arrhythmias, however, 
the reduction of blood pressure leads to a better performance of 
left ventricle and to a reduction of cardiac abnormalities strongly 
related to LA dilation and AF. 
Today, the Mediterranean diet (Med Diet) is considered 
one of the best in terms of its prevention of CVD. A recent 
meta-ana lysis of over 1.5 million healthy subjects shows that a 
greater adherence to Med Diet is significantly associated with 
a reduced risk of overall mortality and cardiovascular mortal-
ity [24]. It has become customary to represent mediterranean 
dietary pattern in the form of a pyramid, the base of that refers 
to foods which are suggested to be consumed most frequently 
(i.e., nonrefined cereals and products such as whole grain bread, 
pasta, rice; vegetables, fruits, olive oil and non-fat or low-fat 
dairy products) and the top of the pyramid to those foods to be 
consumed rarely (red meat and meat products). The remaining 
foods occupy intermediate positions. Med Diet is a diet rich 
in fruits, vegetables, legumes, cereals and olive oil as the only 
source of fat, which are rich in vitamins C and E, b-carotene, 
selenium, a-tocopherol and flavonoids. Moreover, the Med Diet 
pattern is characterized by moderate consumption of wine, espe-
cially during meals, that has been shown to be beneficial, acting 
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positively on lipid metabolism, blood pressure, endothelial dys-
function and obesity. Compared with standard Western diets, 
the Med Diet is considered to be relatively high in a-linolenic 
acid (~2 g per day or 1% of total calories) and low in linoleic 
acid, with an w-3:w-6 ratio of 1:7 [24,25,26]. The Med Diet is 
more effective in promoting weight loss and lowering the ratio of 
total to high-density lipoprotein cholesterol in obese individuals 
than a low-fat diet [27]. 
The Med Diet is associated with a reduction in cardiac death, 
but the underlying mechanisms are poorly understood. It has 
been linked to beneficial effects on inflammatory status. Patients 
with AF have high levels of inflammatory markers, that is, 
C-reactive protein, IL-6 and TNF [28]. Inflammatory infiltra-
tion and fibrosis have been found in atrial biopsies of patients 
with lone atrial fibrillation suggesting a relationship between 
inflammation and AF, supporting the relationship between 
inflammatory status and arrhythmias [29]. However, it is not 
clear whether the inflammatory condition is the cause of AF, or 
the result of repeated attacks and a marker that arrhythmia is 
becoming established. Adherence to the Med Diet is associated 
with lower levels of C-reactive protein (HS-CRP) and IL-6 and 
other markers of endothelial function [30,31]. A study evaluating 
adherence to the Med Diet among healthy adults in the Attica 
region found that those in the highest tertile of adherence aver-
aged 20% lower HS-CRP and 17% lower IL-6 levels, when 
compared with those in the lowest tertile [32]. 
The Med Diet is also associated with more favorable levels of 
adiponectin, an adipocytokine linked to cardiovascular risk [33]. 
Adiponectin is a protein secreted by adipose tissue involved 
in the development of atherosclerosis as demonstrated by its 
association with the stepwise progression of atherogenesis and, 
more importantly, the components of plaque vulnerability [34]. 
Although adiponectin is produced by adipocytes, plasma levels 
are actually inversely proportional to BMI and visceral adipos-
ity. Vascular inflammation is characterized by increased adhe-
sion molecule expression via proinflammatory cytokines such as 
IL-1, IL-8 and TNF-a. Adiponectin partakes in inflammatory 
factor propagation by adhesion molecule expression. In many 
studies assessing the health effects of the Med Diet, the authors 
have speculated about the biological processes that mediate 
its apparent effects, focusing on possible favorable effects of 
olive oil on blood lipids [35,36]. The olive oil, a good source 
of monounsaturated fatty acids (MUFAs), contains phenolic 
compounds that may have antioxidant, anti-inflammatory, and 
anti-thrombotic properties. The protective effect of the Med 
Diet has been attributed, at least in part, to the richness of 
this diet in antioxidants. Not all components of the Med Diet 
are protective, or at least they may not provide equal levels 
of protection. However, food items and nutrients could have 
a synergistic and antagonistic effect within a dietary pattern.
The complex relationship between diet and AF is also medi-
ated by antioxidant intake. The total antioxidant capacity is 
strongly related to the consumption of fruit, vegetables and olive 
oil, and seems to be inversely associated with the consumption of 
red meat [32]. A greater adherence to the Med Diet is associated 
with increased total antioxidant capacity as previously demon-
strated by the ATTICA study. The protective effect is related 
to bioactive compounds in fruits and vegetables that reduce 
oxidative stress, a condition that arises when the formation of 
reactive oxidants and oxidative damage occurs [37]. Fruits and 
vegetables contain at least several hundred different types of 
antioxidants (i.e., electron- or hydrogen-donating reductants) 
that may react directly with such reactive oxidants, forming 
products with much lower reactivity and therefore potentially 
protecting against oxidative damage [38]. A low adherence to the 
Med Diet is associated with the development of persistent AF. 
A study found that, in patients with AF, the prevalent source 
of antioxidants was coffee, whereas control patients derived 
more antioxidants from vegetables, fruit and wine [39]. Intake 
of antioxidants from wine was also lower in patients develop-
ing AF. However, patients with low adherence to the Med Diet 
also had a less healthy lifestyle that could favor the develop-
ment of arrhythmia, suggesting that multiple mechanisms are 
involved. In the Mediterranean, alcoholic beverages of all types 
(mainly wine) are usually consumed with food. It is possible 
that the antioxidant effects of wine (especially red), combined 
with the dietary antioxidants of the Med Diet, might have a 
more beneficial effect on the prevalence of AF, at least in the 
Mediterranean population. The beneficial effects are related to 
specific protective chemical polyphenols found in red wine [39,40].
Recently, an association between the Med Diet and heart rate 
variability (HRV) was suggested [41]. The hypothesis is that the 
dietary components characteristic of the Med Diet, including 
food items, nutrients, and diet-related biochemical reactions 
involving energy generation and nutrient metabolism, may all 
potentially affect HRV through modulating sympathetic and 
parasympathetic activity and central thermoregulatory control. 
The same mechanism has been invoked to understand the impact 
of caffeine intake on the development of arrhythmias. 
Diet & supplements
The Gruppo Italiano per lo Studio della Sopravvivenza 
nell’Infarto Miocardico (GISSI)-Prevenzione trial suggested 
that fish oil supplements leads to a significant reduction in the 
risk of SCD among patients with a recent myocardial infarction 
(MI). The concept that n-3 PUFA may reduce cardiac deaths 
via antiarrhythmic effects is supported by basic science, animal 
and human studies. In vitro studies have shown that acutely 
superfused n-3 PUFA can interact with sodium, potassium and 
calcium ion channels in the cell membrane [42]. Data from Japan 
eicosapentaenoic acid (EPA) Lipid Intervention Study (JELIS), 
however, showed that in a group of hyper cholesterolemic sub-
jects, high-dose EPA did not confer significant protection 
against SCD [43]. Similarly, the Study on Omega-3 Fatty Acid 
and Ventricular Arrhythmia (SOFA) had null results for the n-3 
PUFAs [44]. Indirect evidence that ischemia may be a prerequisite 
for antiarrhythmic effects of n-3 PUFA comes from studies in 
which patients with an implantable defibrillator were random-
ized to n-3 PUFA or control [45,46]. The antiarrhythmic effect 
of fish oil, as demonstrated by the GISSI-prevenzione trial, may 
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be most profound in the setting of acute ischemia or recent MI. 
Outside this setting, when ventricular tachycardia occurs as a 
result of myocardial scar-based re-entry, fish oil may actually 
increase the risk of ventricular tachycardia or ventricular fibrilla-
tion. By contrast, a study carried out on patients with idiopathic 
dilated cardiomyopathy reported that n-3 PUFAs administration 
was associated with favorable effects on parameters related to 
arrhythmic risk suggesting that the antiarrhythmic activity was 
independent from the anti-ischemic effects [47]. These hypotheses 
only hightlighted the need for further research. 
Patients are increasingly using dietary supplements and 
herbal products for purportedly preventive and therapeutic pur-
poses [48]. Some products have direct effects on the cardiovas-
cular or hemostatic system, whereas others have indirect effects 
through interactions with medications that could lead to seri-
ous consequences [49]. Common herbal remedies that produce 
adverse effects on the cardiovascular system include St. John’s 
wort, motherwort, ginseng, gingko biloba, garlic, grapefruit 
juice, hawthorn, saw palmetto, danshen, echinacea, tetrandrine, 
aconite, yohimbine, gynura, licorice and black cohosh. Some 
of them, that is, oleander, ginkgo and gossypol, could provoke 
arrhythmias. Some herbal products (aloe vera, bitter orange, 
echinacea, ginkgo biloba, ginseng, guarana, hawthorn, horny 
goat weed, licorice, lily of the valley, night-blooming cereus, 
oleander, rhodiola and St John’s wort) induce arrhythmias by 
prolonging QT interval or interfering with antiarrhythmic 
drugs [50]. Most (64%) of the patients with a diagnosis of AF or 
ischemic heart disease reported concomitant use of alternative 
therapies and prescription drugs [51]. There is a clear need for 
better public and physician understanding of herbal products 
through health education, early detection and management of 
herbal toxicities, scientific scrutiny of their use, and research on 
their effectiveness and safety [50]. Regulatory policies are also 
needed to protect people from untoward effects on their health.
Coffee, caffeine & atrial fibrillation
The associations between coffee, caffeine and AF have had con-
flicting results [52–54]. Caffeine is the most widely consumed 
behaviorally active substance in the world and almost all comes 
from dietary sources, most of it from coffee [55]. Caffeine is a 
nonselective competitive antagonist of adenosine receptor sub-
types A1 and A2A in concentrations typically consumed by 
humans. At higher concentrations, caffeine can induce intracel-
lular calcium release and phosphodiesterase inhibition. Caffeine 
is an alkaloid that is naturally present in coffee beans; however, 
it is also present in a number of dietary sources consumed world-
wide, in tea, cocoa beverages, chocolate bars, soft drinks and 
energy drinks.
Studies evaluating the acute effects of caffeine on heart 
rate found controversial results. After acute ingestion of 100 
or 200 mg of caffeine, a significant decrease in heart rate was 
observed in nonhabitual coffee consumers [56], whether in habit-
ual coffee consumers, the lack of this effect on heart rate depends 
on rapid tachyphylaxis of caffeine [57]. These results underline 
the different response in habitual and nonhabitual consumers as 
previously reported by authors evaluating hypertensive patients. 
Different findings were also found in two studies investigating 
the effects of excessive, toxic caffeine ingestion on HRV [58,59]. 
Interestingly, the physiologic effects of caffeine differ in men 
and women. In the Women Health Study, caffeine consump-
tion was not associated with an increased risk of incident AF in 
initially healthy middle-aged women [60]. The clinical effect of 
intake of caffeine from coffee, tea and caffeinated soda on AF 
remains inconclusive. There are some differences among coffee 
and caffeine intake. Coffee is a complex beverage that includes 
hundreds of substances including antioxidants. In healthy vol-
unteers the acute ingestion of caffeinated instant coffee does 
not result in supraventricular arrhythmias [61]. However, many 
patients with paroxysmal AF indicate coffee intake as a trigger-
ing factor for arrhythmia, and there is a fairly widespread belief 
that caffeine intake is related to the development of AF [62]. In 
a case–control study we found that increasing levels of coffee 
consumption were associated with a significantly greater risk of 
acute AF [63]. High espresso coffee consumption (>three cups/
day) was associated with an increased risk of AF, moreover, 
habitual drinkers had a low probability of spontaneous conver-
sion of the arrhythmia. Caffeine may mediate AF by resulting in 
neurohormonal stimulation and sympathetic activation and the 
effects could be enhanced in nonhabitual coffee drinkers [64,65]. 
As for habitual intake, the FHS and a Danish study showed 
no association of daily caffeine intake with incident AF [53,66]. 
Interestingly, a recent incidence of acute stress is associated with 
an increase in coffee consumption in almost all subjects, habitual 
and nonhabitual drinkers [67]. Other studies identified moder-
ate coffee consumption (one to four cups/day) as a contributor 
to AF risk [68], whereas another study showed that caffeine was 
associated with less successful cardioversion in participants with 
hypertension [35]. It is plausible that the effect of caffeine varies 
in habitual versus nonhabitual consumers and also depends on 
the dose, on the modality of preparation and on the modality 
of intake, for example, coffee after meals. Further studies are 
needed to clarify the relation of caffeine exposure to risk of 
incident and recurrent AF in healthy individuals and in patients 
with a predisposition for AF. 
Alcohol & atrial fibrillation
An interesting ana lysis was carried out on the association of modi-
fiable factors, such as coffee intake, cigarette smoking, alcohol 
consumption and physical activity with QT interval duration [69]. 
In the large sample representative of the general US population, 
the authors found no association between QT interval duration 
and coffee or tea intake, cigarette smoking, physical activity, or 
total alcohol intake, although binge drinking was associated with 
an increased QT duration, particularly in men. 
Several studies have identified a variety of ECG abnormalities, 
including prolonged QT interval in chronic alcoholics or heavy 
drinkers. Abnormalities of electrolytes, increased sympathetic 
tone and catecholamine secretion, as well as cardiac cellular 
infiltrate, hypertrophy and fibrosis are frequently seen in chronic 
alcoholism, which may all cause changes in QT interval [70–72]. 
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Electromechanical experiments also suggest a concentration 
dependent effect of alcohol on action potential duration, with a 
decreased duration of repolarization at very high concentrations 
of alcohol but no effect at low concentrations [73]. 
The proarrhythmic effects of ethanol are controversial and 
strongly dependent on the amount of alcohol consumed and the 
pattern of drinking. Excessive alcohol intake increases the risks 
of motor vehicle accidents, stroke, cardiomyopathy, cardiac dys-
rhythmia and SCD [74]. Acute alcohol intake and binge drinking 
have been related to AF [75], whereas, moderate alcohol intake 
was not associated with a higher risk of SCD [76]. Moderate alco-
hol consumption may lower the risk of some cardiovascular dis-
eases but the association with arrhythmic disorders is less clear. 
Epidemiologic data of the long-term relation of alcohol intake 
have been inconsistent. Data from the Cardiovascular Health 
Study showed no effect of alcohol intake on AF [77], whereas the 
FHS study found that moderate-to-heavy alcohol consumption 
(more than three drinks/day; 36 g alcohol) is significantly associ-
ated with increased AF risk in men [78]. A similar association has 
been identified in women, where the consumption of more than 
two drinks/day (equivalent to 25 g alcohol/day) increased AF 
risk [79]. Recently, it has been hypothesized that not only episodic 
but also habitual heavy alcohol consumption is associated with 
the risk of AF [80]. The arrhythmogenicity of chronic alcohol 
exposure may stem from alcoholic cardiomyopathy, increased 
oxidative stress, neurohormonal activation and altered calcium 
homeostasis [81,82]. 
A recent meta-ana lysis of 14 studies, evaluating the relation-
ship between AF and alcohol, concluded that habitual heavy 
alcohol drinking is associated with an increased risk of AF, 
although several study limitations exist and must be recognized 
[83]. The relationship between daily alcohol consumption and 
the risk of AF was explained by a linear dose-response model, 
suggesting that not consuming alcohol at all is the most favor-
able behavior for avoiding AF, rather than moderate alcohol 
consumption. 
Similarly, the healthy effects of alcohol intake are also contro-
versial and strongly depend on dose and modality of intake [84]. 
In the ana lysis of nine nationally representative samples of the 
US population, comprising over 10,000 cardiovascular deaths, 
light and moderate alcohol consumption was associated with 
lower cardiovascular mortality, whereas heavy alcohol consump-
tion was not [85]. The magnitude of lower risk was generally 
strongest for coronary heart disease mortality and among non-
Hispanic whites. These data support previous epidemiological 
studies that have found lower rates of CVD among moderate 
drinkers [86,87]. Most studies report J-shaped curves, whereby 
light-to-moderate drinkers have less risk of CV events than 
abstainers, and heavy drinkers are at the highest risk [88–90]. 
A recent meta-ana lysis of 12,819 patients with CVD showed 
that light-to-moderate alcohol consumption (5–25 g/day) was 
significantly associated with a lower incidence of cardiovascular 
and all-cause mortality [91]. 
Mechanisms supporting antiatherosclerotic effects of mod-
erate intake of alcohol include beneficial regulation of lipids 
and fibrinolysis, decreased platelet aggregation and coagula-
tion factors, beneficial effects on endothelial function, and 
inflammation and insulin resistance [92].
Moreover, in the Mediterranean alcohol, mainly wine, is mostly 
consumed during meals, and reports now suggest that wines con-
tain antioxidant compounds and may modulate the health effects 
of other nutritional compounds in the stomach [92,93]. 
Expert commentary & five-year view
Despite great progress and success in the improvement of cardio-
vascular outcomes, the gains of recent years are likely to be over-
shadowed by the sheer volume of CVD that will accrue from 
untreated risk factors. The greatest health gains could come from 
preventive strategies. One example of such an approach is the 2010 
Dietary Guidelines for Americans which recommend balancing 
of calories, reduction of salt and decrease of cholesterol intake. 
Healthy lifestyle influences the development of  arrhythmias and 
is strongly related to AF development.
Atrial fibrillation is the most frequent arrhythmia in clinical 
practice and its prevalence is growing. The majority of patients 
with AF had a structural cardiac disease; however, a small num-
ber of them had no morphological modification of the heart. The 
impact of a nonhealthy lifestyle on the development of AF strongly 
depends on the relationship between the obesity and cardiac cham-
ber changes leading to atrial dilation and AF. Furthermore, some 
‘nonhealthy’ habits could directly influence the development of 
arrhythmias. Coffee, caffeine and alcohol demonstrated different 
effects on AF, mainly related to the global lifestyle of subjects. 
Coffee and caffeine intake has effects on AF according to the 
modality of preparation, the daily quantity of caffeine and the 
relationship with other food. Adherence to the Med Diet strongly 
influenced the outcome of cardiac disease and, similarly, the intake 
of coffee and alcohol within a healthy diet seems to contribute to a 
good bioavailability of antioxidants and anti-inflammatory food. 
The controversial data emerging from clinical trials are mainly 
due to selection criteria and are affected by the difficulties of col-
lecting data on food intake and, in particular, on alcohol intake. 
A healthy lifestyle is associated with a reduction of CV events 
through weight control and visceral adiposity control. The ben-
eficial effect on AF is related to the reduction of structural cardiac 
disease, the reduction of atherosclerosis and of atrial and ventricu-
lar dysfunction. Refering to the recent guidelines we emphasize 
the importance of education and the influence of communities 
to enable and encourage healthy choices.
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